SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-079131
Filing Date
2023-07-07
Accepted
2023-07-07 16:16:06
Documents
2
Period of Report
2023-07-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320607-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320607-2_4seq1.xml 4 5285
2 EXHIBIT 24.1 tm2320607d2_ex24-1.htm EX-24.1 9114
  Complete submission text file 0001104659-23-079131.txt   16031
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 HAZELWOOD COURT WARREN NJ 07059
Business Address
Miller Larry Lee (Reporting) CIK: 0001603584 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 231076967